Learn more

KYMERA THERAPEUTICS INC

Overview
  • Total Patents
    39
  • GoodIP Patent Rank
    39,155
About

KYMERA THERAPEUTICS INC has a total of 39 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are BLADE THERAPEUTICS INC, CHANGZHOU YINSHENG PHARMACEUTICAL CO LTD and TETRA DISCOVERY PARTNERS LLC.

Patent filings per year

Chart showing KYMERA THERAPEUTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ji Nan 36
#2 Zhang Yi 29
#3 Mainolfi Nello 25
#4 Weiss Matthew M 21
#5 Kluge Arthur F 17
#6 Zheng Xiaozhang 7
#7 Sintchak Michael D 5
#8 Fleming Paul R 4
#9 Weiss Matthew 2
#10 Yang Bin 1

Latest patents

Publication Filing date Title
WO2021011871A1 Mertk degraders and uses thereof
WO2021011868A1 Irak degraders and uses thereof
WO2021011634A1 Protein degraders and uses thereof
WO2021011631A1 Fused-glutarimide crbn ligands and uses thereof
WO2020264490A1 Irak degraders and uses thereof
WO2020264499A1 Irak degraders and uses thereof
WO2020251969A1 Smarca degraders and uses thereof
WO2020251972A1 Smarca degraders and uses thereof
WO2020251974A1 Smarca inhibitors and uses thereof
WO2020251971A1 Smarca degraders and uses thereof
WO2020206424A1 Stat degraders and uses thereof
WO2020113233A1 Irak degraders and uses thereof
WO2020010210A1 Mertk degraders and uses thereof
WO2020010177A1 Tricyclic crbn ligands and uses thereof
WO2020010227A1 Protein degraders and uses thereof
US2021002296A1 Protein degraders and uses thereof
WO2019140387A1 Crbn ligands and uses thereof
CN112105385A IRAK degrading agents and uses thereof
WO2019060693A1 Crbn ligands and uses thereof
WO2019060742A1 Protein degraders and uses thereof